BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 34360786)

  • 1. Clinical Proteomics of Biofluids in Haematological Malignancies.
    Dunphy K; O'Mahoney K; Dowling P; O'Gorman P; Bazou D
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery.
    Zamò A; Cecconi D
    J Proteomics; 2010 Jan; 73(3):508-20. PubMed ID: 19755177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
    Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
    Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
    J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications.
    Dayon L; Cominetti O; Affolter M
    Expert Rev Proteomics; 2022 Feb; 19(2):131-151. PubMed ID: 35466824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteomics techniques and their application in haemato-oncologic malignancies].
    Zelená J; Hájek R
    Cas Lek Cesk; 2007; 146(7):586-92. PubMed ID: 17722845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics and the haematologist.
    Rees-Unwin KS; Morgan GJ; Davies FE
    Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Derived Extracellular Vesicles as a Novel Source of Protein Biomarkers for Cancer Diagnosis and Monitoring.
    Ruhen O; Meehan K
    Proteomics; 2019 Jan; 19(1-2):e1800155. PubMed ID: 30467990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer proteomics: developments in technology, clinical use and commercialization.
    Yeat NC; Lin C; Sager M; Lin J
    Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.
    Dixit A; Mehta R; Singh AK
    Cell Mol Neurobiol; 2019 Oct; 39(7):901-915. PubMed ID: 31190159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of oral fluids for disease detection.
    Khurshid Z; Warsi I; Moin SF; Slowey PD; Latif M; Zohaib S; Zafar MS
    Adv Clin Chem; 2021; 100():205-253. PubMed ID: 33453866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of biofluids for biomarker research.
    Xu X; Veenstra TD
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1403-12. PubMed ID: 21136789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
    Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
    J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.
    Wu C; Duan J; Liu T; Smith RD; Qian WJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():57-68. PubMed ID: 26868616
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.